Dokumentuaren aipamena

APA (7th ed.) Zitazioa
Ballatore, Z., Vanacker, H., Chiari, R., & Bachelot, T. (2025). Exceptional responses to Trastuzumab deruxtecan in HER2-positive breast cancer: Two illustrative case reports. Frontiers Media S.A.
Chicago Style (17th ed.) Zitazioa
Ballatore, Zelmira, Helene Vanacker, Rita Chiari, eta Thomas Bachelot. Exceptional Responses to Trastuzumab Deruxtecan in HER2-positive Breast Cancer: Two Illustrative Case Reports. Frontiers Media S.A, 2025.
MLA (9th ed.) Zitazioa
Ballatore, Zelmira, et al. Exceptional Responses to Trastuzumab Deruxtecan in HER2-positive Breast Cancer: Two Illustrative Case Reports. Frontiers Media S.A, 2025.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.